Detecting Blood-Based Biomarkers in Metastatic Breast Cancer: A Systematic Review of Their Current Status and Clinical Utility

Detecting Blood-Based Biomarkers in Metastatic Breast Cancer: A Systematic Review of Their Current Status and Clinical Utility

Reviews on circulating biomarkers in breast cancer usually focus on one single biomarker or a selective group of biomarkers. An overview summarizing the discovery and evaluation of all blood-based biomarkers in metastatic breast cancer is lacking. This systematic review aims to identify the availabl...

Full description

Bibliographic Details
Main Authors:	A. M. Sofie Berghuis, Hendrik Koffijberg, Jai Prakash, Leon W. M. M. Terstappen, Maarten J. IJzerman
Format:	Article
Language:	English
Published:	MDPI AG 2017-02-01
Series:	International Journal of Molecular Sciences
Subjects:	metastatic breast cancer liquid biopsy circulating biomarkers blood-based biomarkers circulating tumor cells (CTCs) utility developmental stages development evaluation and application chart (DEAC)
Online Access:	http://www.mdpi.com/1422-0067/18/2/363

Similar Items

Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel
by: Ingeborg E. de Kruijff, et al.
Published: (2019-08-01)

Emerging Lab-on-a-Chip Approaches for Liquid Biopsy in Lung Cancer: Status in CTCs and ctDNA Research and Clinical Validation
by: Ângela Carvalho, et al.
Published: (2021-04-01)

Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response
by: Ning Jia, et al.
Published: (2019-05-01)

Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
by: Vincenzo Di Nunno, et al.
Published: (2018-09-01)

Progress and application of circulating tumor cells in non-small cell lung cancer
by: Huizhu Qian, et al.
Published: (2021-09-01)

Circulating <i>PTGS2</i>, <i>JAG1</i>, <i>GUCY2C</i> and <i>PGF</i> mRNA in Peripheral Blood and Serum as Potential Biomarkers for Patients with Metastatic Colon Cancer
by: Cristina Jimenez-Luna, et al.
Published: (2021-05-01)

Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial
by: Anna-Maria Larsson, et al.
Published: (2018-06-01)

Can Biomarker Assessment on Circulating Tumor Cells Help Direct Therapy in Metastatic Breast Cancer?
by: Natalie Turner, et al.
Published: (2014-03-01)

Diagnosis of Prostate Cancer, from Conventional Methods Towards the New Promising CTCs
by: M. Shahrabi-Farahani, et al.
Published: (2016-02-01)

Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
by: Daniel Fernandez-Garcia, et al.
Published: (2019-12-01)

Clinical utility of comprehensive circulating tumor DNA genotyping compared with standard of care tissue testing in patients with newly diagnosed metastatic colorectal cancer
by: Alba, E., et al.
Published: (2022)

Development of an immunofluorescent AR-V7 circulating tumor cell assay – A blood-based test for men with metastatic prostate cancer
by: David Lu, et al.
Published: (2020-10-01)

Clinical Applications of Circulating Tumor DNA, Circulating Tumor Cells, and Exosomes as Liquid Biopsy-Based Tumor Biomarkers
by: Xiaoshuang Yan, et al.
Published: (2020-08-01)

Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer
by: Carlos Casas-Arozamena, et al.
Published: (2020-02-01)

Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential
by: Marianne Trier Bjerre, et al.
Published: (2020-05-01)

Detection and Prognostic Relevance of Circulating and Disseminated Tumour Cell in Dogs with Metastatic Mammary Carcinoma: A Pilot Study
by: Laura Marconato, et al.
Published: (2019-02-01)

Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions
by: Zhuo eZhang, et al.
Published: (2015-09-01)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
by: Qianwei Ye, et al.
Published: (2019-07-01)

Liquid Biopsy for Small Cell Lung Cancer either De Novo or Transformed: Systematic Review of Different Applications and Meta-Analysis
by: Elio Gregory Pizzutilo, et al.
Published: (2021-05-01)

Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients
by: I. E. de Kruijff, et al.
Published: (2021-06-01)

Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA)
by: Minji Lim, et al.
Published: (2018-02-01)

The potential for liquid biopsies in the precision medical treatment of breast cancer
by: Victoria A. Forte, et al.
Published: (2016-03-01)

The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast Cancer
by: Stefan Stefanovic, et al.
Published: (2020-03-01)

Circulating microRNAs as Promising Biomarkers in Colorectal Cancer
by: Óscar Rapado-González, et al.
Published: (2019-06-01)

The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review
by: Frederik van Delft, et al.
Published: (2020-04-01)

Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial
by: Marianna Alunni-Fabbroni, et al.
Published: (2019-10-01)

Circulating microRNAs from the Molecular Mechanisms to Clinical Biomarkers: A Focus on the Clear Cell Renal Cell Carcinoma
by: Claudia Tito, et al.
Published: (2021-07-01)

Liquid Biopsy in Oral Cancer
by: Fatima Lousada-Fernandez, et al.
Published: (2018-06-01)

Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
by: Laura Muinelo-Romay, et al.
Published: (2018-08-01)

Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung Cancer
by: Boris Duchemann, et al.
Published: (2020-12-01)

Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
by: Chelala, C., et al.
Published: (2022)

Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein
by: Sara R. Bang-Christensen, et al.
Published: (2019-08-01)

Circulating Long Non-Coding RNAs as Novel Potential Biomarkers for Osteogenic Sarcoma
by: Sutpirat Moonmuang, et al.
Published: (2021-08-01)

Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial
by: François-Clément Bidard, et al.
Published: (2019-05-01)

Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma
by: Julie Niogret, et al.
Published: (2020-05-01)

Next-Generation Cancer Biomarkers: Extracellular Vesicle DNA as a Circulating Surrogate of Tumor DNA
by: Samuel Amintas, et al.
Published: (2021-02-01)

Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients
by: Rebeca Lozano, et al.
Published: (2021-05-01)

Clinical Applications of Liquid Biopsy in Gastric Cancer
by: Mihaela Chivu-Economescu, et al.
Published: (2021-09-01)

Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring
by: Paula Kamińska, et al.
Published: (2021-09-01)

Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer
by: Elena Elez, et al.
Published: (2019-09-01)